Evidence map›Paper›PMID 31582831›Full record

ReviewNature nanotechnology2019

Path towards graphene commercialization from lab to market.

Wei Kong, Hyun Kum, Sang-Hoon Bae, Jaewoo Shim, Hyunseok Kim, Lingping Kong, Yuan Meng, Kejia Wang, Chansoo Kim, Jeehwan Kim

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature nanotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Where is my graphene battery?Nature nanotechnology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Controlling the Orientation of MoSNanomaterials (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wei KongDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Hyun KumDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Sang-Hoon BaeDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jaewoo ShimDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Hyunseok KimDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3091-8413
Lingping KongDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Yuan MengDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-5409-5610
Kejia WangDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Chansoo KimDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jeehwan KimDepartment of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. jeehwan@mit.edu.ORCID http://orcid.org/0000-0002-1547-0967

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ground-breaking demonstration of the electric field effect in graphene reported more than a decade ago prompted the strong push towards the commercialization of graphene as evidenced by a wealth of graphene research, patents and applications. Graphene flake production capability has reached thousands of tonnes per year, while continuous graphene sheets of tens of metres in length have become available. Various graphene technologies developed in laboratories have now transformed into commercial products, with the very first demonstrations in sports goods, automotive coatings, conductive inks and touch screens, to name a few. Although challenges related to quality control in graphene materials remain to be addressed, the advancement in the understandings of graphene will propel the commercial success of graphene as a compelling technology. This Review discusses the progress towards commercialization of graphene for the past decade and future perspectives.

Identifiers

PMID31582831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.